CXCL10 and infection: Our results revealed that the protein release of IP-10 and TNF-α after CV-A16 infection was relatively low when given a high dose of Eldelumab was used, but the protein release of IP-10 and TNF-α after CV-A16 infection was relatively high when given a low dose of Eldelumab was used (Figure 4B), which was in line with data of the above flow cytometry data described above.